India’s fourth largest Pharma Company Piramal Healthcare Limited (PHL) is ideally poised to give good performance in the coming quarters. Unlike Divis and Glenmark, Piramal is reasonable valued and like Sun Pharma, it is going to post good results in this quarter. PHL is improving its core generic business while betting big on Contract Research and Manufacturing Services (CRAMS).
Discuss Add this link to... Tell a friendBury Add to:
| Bookmarks
Here you can read interesting desi stuff from around the globe as it happens, and participate by submitting and voting for content. Basically, you decide whats on the dubbagol pages!
Comments